Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Active, not recruiting · NCT03496883 · Registry updated 2026-01-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-01-21 | NCT03496883 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Joseph Broderick, MD | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 370 |
| Novo Nordisk A/S | 181 |
88 results · Page 1 of 4
Research sites
Swipe the table sideways for more columns.